Segall Bryant & Hamill, LLC Edwards Lifesciences Corp Transaction History

Segall Bryant & Hamill, LLC

$5.57 Billion
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $138,282 - $186,386	-1,996 Reduced 7.24%	25,561 $1.77 Million
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $369,031 - $427,597	4,533 Added 19.69%	27,557 $2.6 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $6,906 - $7,859	-93 Reduced 0.4%	23,024 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.58 Million - $2.02 Million	23,117 New	23,117 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.93 Million - $2.51 Million	23,417 New	23,417 $1.94 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $11,677 - $17,316	-135 Reduced 0.56%	23,949 $2.28 Million
Q1 2022 May 13, 2022	SELL	$101.96 - $128.34 $527,846 - $664,416	-5,177 Reduced 17.69%	24,084 $2.84 Million
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $64,034 - $78,669	-602 Reduced 2.02%	29,261 $3.79 Million
Q3 2021 Nov 03, 2021	BUY	$102.91 - $122.75 $12,349 - $14,730	120 Added 0.4%	29,863 $3.38 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $83,336 - $104,131	994 Added 3.46%	29,743 $3.08 Million
Q1 2021 May 13, 2021	SELL	$78.68 - $90.67 $63,494 - $73,170	-807 Reduced 2.73%	28,749 $2.4 Million
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $26,883 - $34,211	-375 Reduced 1.25%	29,556 $2.7 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $85,667 - $111,486	-1,275 Reduced 4.09%	29,931 $2.39 Million
Q2 2020 Aug 14, 2020	BUY	$57.54 - $76.95 $1.19 Million - $1.6 Million	20,735 Added 198.02%	31,206 $2.16 Million
Q4 2019 Feb 11, 2020	SELL	$71.7 - $82.09 $16,419 - $18,798	-229 Reduced 2.14%	10,471 $814,000
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $8,361 - $9,661	-150 Reduced 1.38%	10,700 $0
Q4 2018 Feb 15, 2019	SELL	$46.41 - $56.94 $18,424 - $22,605	-397 Reduced 3.53%	10,850 $554,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $21,022 - $26,693	-460 Reduced 3.93%	11,247 $0
Q2 2018 Aug 08, 2018	BUY	$42.45 - $51.3 $13,371 - $16,159	315 Added 2.77%	11,707 $0
Q1 2018 May 16, 2018	SELL	$37.19 - $47.45 $1,487 - $1,898	-40 Reduced 0.35%	11,392 $0
Q4 2017 Feb 15, 2018	BUY	$33.79 - $39.39 $4,629 - $5,396	137 Added 1.21%	11,432 $0
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $409,895 - $438,584	11,295	11,295 $0

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Segall Bryant & Hamill, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Segall Bryant & Hamill, LLC with notifications on news.

Account